Transfer of complex frontline anticancer therapy to a developing country: The St. Jude osteosarcoma experience in Chile

Pediatric Blood and Cancer

Volumn 50, Issue 6, 2008, Pages 1143-1146

  Rivera, Gaston K ^a,b   Quintana, Juan ^c,d   Villarroel, Milena ^c,d   Santana, Victor M ^a,b   Rodriguez Galindo, Carlos ^a,b   Neel, Michael D ^a   Velez, George ^a   Ribeiro, Raul C ^a,b   Daw, Najat C ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c HOSPITAL LUIS CALVO MACKENNA   (Chile)

^d Chilean National Pediatric Oncology Group (PINDA)   (Chile)

Author keywords

Collaborative clinical research trial; Osteosarcoma; Pediatric oncology; Surgery

Indexed keywords

HEMOPOIETIC GROWTH FACTOR;

ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER STAGING; CANCER THERAPY; CHILD; CHILE; CLINICAL PROTOCOL; CLINICAL RESEARCH; CONFIDENCE INTERVAL; DEVELOPING COUNTRY; DISEASE FREE SURVIVAL; EXPERIENCE; FOLLOW UP; HUMAN; IMAGING; INFORMATION PROCESSING; INTENSIVE CARE; LIMB AMPUTATION; LIMB SALVAGE; MAJOR CLINICAL STUDY; MONITORING; OSTEOSARCOMA; PATHOLOGY; PATIENT CARE; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

BONE NEOPLASMS; CHILD; CHILE; DEVELOPING COUNTRIES; HOSPITALS, PEDIATRIC; HUMANS; INTERNATIONAL COOPERATION; OSTEOSARCOMA; TENNESSEE;

EID: 42349109548     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21444     Document Type: Article

References (11)

1. Masera G, Baez F, Biondi A, et al. North-South twinning in pediatric hematology oncology: The La Mascota programme, Nicaragua. Lancet 1998;352:1923-1926.
2. Ribeiro RC, Pui CH. Saving the children-improving childhood cancer treatment in developing countries. N Engl J Med 2005;352:2158-2160.
3. Wilimas JA, Ribeiro RC. Pediatric, hematology-oncology outreach for developing countries. Hematol Oncol Clin North Am 2001;15:775-787.
4. Metzger ML, Howard SC, Fu LC, et al. Outcome of childhood acute lymphoblastic leukemia in resource-poor countries. Lancet 2003;362:706-708.
5. Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004;291:2471-2475.
6. Howard SC, Marinoni M, Castillo L, et al. Improving outcomes for children with cancer in low-income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part I. Pediatr Blood Cancer 2007;48:364-369.
7. Palma J, Mosso C, Campbell M, et al. Establishment of a pediatric HSCT program in a public hospital in Chile. Pediatr Blood Cancer 2006;46:803-810.
8. Meyer WH, Pratt CB, Poquette CA, et al. Carboplatin/ifosfamide window therapy for osteosarcoma. Results of the St. Jude Children's Research Hospital OS 91 trial. J Clin Oncol 2001;19:171-182.
9. Daw NC, Billups CA, Rogriguez-Galindo C, et al. Metastatic osteosarcoma: Results of two consecutive therapeutic trials at St. Jude Children's Research Hospital. Cancer 2006;106:403-412.
10. Chilean Ministerio de Salud. February 22, 2007 http://www.minsal.cl/ (accessed Feb. 22, 2007).
11. Vargas L. Avances en el tratamiento del cancer infantil en Chile. Diez años del Programa Infantil de Drogas Antineoplasicas (PINDA). Rev Chil Ped 1998;69:270-278.